What is it about?
Participation of patients from the Middle East in testing of new drugs lags far behind participation in drug consumption
Featured Image
Why is it important?
Drugs sold and consumed by patients in the Middle East have not been adequately tested on populations with similar genetic and cultural profile
Perspectives
Our paper demonstrates that patients in the Middle East are consuming medications in development of which patients from the Middle East region (sharing similar genetic and cultural profile) have not participated. This presents an ethical dilemma to the pharma industry, medical institutions, and the governments of countries in the Middle East.
Vladimir Misik
LongTaal
Read the Original
This page is a summary of: Recent trends in globalization of industry R&D clinical trials: are emerging markets losing their allure?, Applied Clinical Research Clinical Trials and Regulatory Affairs, June 2017, Bentham Science Publishers,
DOI: 10.2174/2213476x04666170620101442.
You can read the full text:
Contributors
The following have contributed to this page
